CrossBridge Bio

CrossBridge Bio

CrossBridge Bio is a Houston-based biotech startup that develops antibody-drug conjugates (ADCs) for cancer treatment. Founded in 2023, the company is notable for its innovative approach to combining targeted therapy with chemotherapy, aiming to kill cancer cells while preserving healthy tissue.

Total raised
$300M
tracked to date
Latest round
$300M
Jun 3, 2026
Known investors
6
led by Texas Medical Center Venture Fund

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 USA Funding Report

Read the Q2 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 USA Funding Report</a>

Funding history

  1. 1
    $300MJun 3, 2026

    Led by Texas Medical Center Venture Fund

    Announcement ↗

Founder

Michael Torres
Michael Torres
Co-founder and CEO
LinkedIn ↗

Investors in CrossBridge Bio

Backers from this company's tracked funding rounds.

  • TTexas Medical Center Venture FundLead investorVC firm
  • CCE-VenturesVC firm
  • AAlexandria Venture InvestmentsVC firm
  • PPortal InnovationsVC firm
  • LLinden Lake LabsVC firm
  • CCancer Prevention and Research Institute of TexasVC firm

CrossBridge Bio in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile